<output id="zjvxt"><video id="zjvxt"></video></output>

<video id="zjvxt"><delect id="zjvxt"><font id="zjvxt"></font></delect></video><font id="zjvxt"></font>

<p id="zjvxt"><output id="zjvxt"><delect id="zjvxt"></delect></output></p>

<p id="zjvxt"><output id="zjvxt"><delect id="zjvxt"></delect></output></p>
<noframes id="zjvxt">
<output id="zjvxt"></output><p id="zjvxt"></p>
<output id="zjvxt"></output>

<p id="zjvxt"></p>
<p id="zjvxt"></p>

<p id="zjvxt"></p>
<video id="zjvxt"><output id="zjvxt"></output></video>
<output id="zjvxt"><delect id="zjvxt"></delect></output>
<video id="zjvxt"><output id="zjvxt"></output></video>

<video id="zjvxt"></video>

<p id="zjvxt"><output id="zjvxt"></output></p>

<video id="zjvxt"><output id="zjvxt"></output></video><video id="zjvxt"></video>
<output id="zjvxt"><output id="zjvxt"></output></output>
<p id="zjvxt"><delect id="zjvxt"><font id="zjvxt"></font></delect></p>

<p id="zjvxt"><delect id="zjvxt"><font id="zjvxt"></font></delect></p>
<video id="zjvxt"></video><p id="zjvxt"></p>
<video id="zjvxt"><output id="zjvxt"><delect id="zjvxt"></delect></output></video>

<video id="zjvxt"><output id="zjvxt"></output></video>
<p id="zjvxt"><delect id="zjvxt"></delect></p>

<output id="zjvxt"><output id="zjvxt"></output></output><output id="zjvxt"></output>
<p id="zjvxt"><output id="zjvxt"></output></p>
<p id="zjvxt"></p>
<p id="zjvxt"></p>

武漢先路醫藥科技股份有限公司歡迎您的光臨Welcome !
?
?
當前位置:首頁 > 新聞中心 > 行業動態

國家藥監局藥審中心關于發布《化學仿制藥參比制劑遴選申請資料要求》的通告(2020年第32號)

來源:CFDE  發布時間:2020-10-19  瀏覽量:1215

國家藥監局藥審中心關于發布《化學仿制藥參比制劑遴選申請資料要求》的通告(2020年第32號)

發布日期:20201019

       為更好地服務申請人,進一步提高參比制劑遴選工作的質量和效率,藥審中心組織制定了《化學仿制藥參比制劑遴選申請資料要求》(見附件),根據《國家藥監局綜合司關于印發藥品技術指導原則發布程序的通知》(藥監綜藥管〔2020〕9號)要求,經國家藥品監督管理局審核同意,現予發布,自發布之日起施行。
       特此通告。
                                                                                                                           國家藥品監督管理局藥品審評中心
                                                                                                                                         2020年10月16日

        附件1:化學仿制藥參比制劑遴選申請資料要求

?
網站首頁| 關于先路| 產品中心| 研發體系| 合作伙伴| 新聞中心| 職業機會| 聯系我們
国产一级黄片

<output id="zjvxt"><video id="zjvxt"></video></output>

<video id="zjvxt"><delect id="zjvxt"><font id="zjvxt"></font></delect></video><font id="zjvxt"></font>

<p id="zjvxt"><output id="zjvxt"><delect id="zjvxt"></delect></output></p>

<p id="zjvxt"><output id="zjvxt"><delect id="zjvxt"></delect></output></p>
<noframes id="zjvxt">
<output id="zjvxt"></output><p id="zjvxt"></p>
<output id="zjvxt"></output>

<p id="zjvxt"></p>
<p id="zjvxt"></p>

<p id="zjvxt"></p>
<video id="zjvxt"><output id="zjvxt"></output></video>
<output id="zjvxt"><delect id="zjvxt"></delect></output>
<video id="zjvxt"><output id="zjvxt"></output></video>

<video id="zjvxt"></video>

<p id="zjvxt"><output id="zjvxt"></output></p>

<video id="zjvxt"><output id="zjvxt"></output></video><video id="zjvxt"></video>
<output id="zjvxt"><output id="zjvxt"></output></output>
<p id="zjvxt"><delect id="zjvxt"><font id="zjvxt"></font></delect></p>

<p id="zjvxt"><delect id="zjvxt"><font id="zjvxt"></font></delect></p>
<video id="zjvxt"></video><p id="zjvxt"></p>
<video id="zjvxt"><output id="zjvxt"><delect id="zjvxt"></delect></output></video>

<video id="zjvxt"><output id="zjvxt"></output></video>
<p id="zjvxt"><delect id="zjvxt"></delect></p>

<output id="zjvxt"><output id="zjvxt"></output></output><output id="zjvxt"></output>
<p id="zjvxt"><output id="zjvxt"></output></p>
<p id="zjvxt"></p>
<p id="zjvxt"></p>